therapeutic 1,360 words KG: ent-gene-efa85237
Contents

NfL Reduction Therapy: Neuroprotective Strategies for Neurodegenerative Diseases

🔬 Protein Info
Gene Symbolent-gene-efa85237
KG Connections7 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (42)

Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69
R-Loop Resolution Enhancement Therapy
Score: 0.68
GAP43-mediated tunneling nanotube stabilization enhances neu
Score: 0.67
Arginine Methylation Enhancement Therapy
Score: 0.65
Glial Glycocalyx Remodeling Therapy
Score: 0.65
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.65
SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.61
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
TREM2-Dependent Microglial Senescence Transition
Score: 0.58
Temporal Decoupling via Circadian Clock Reset
Score: 0.54
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.48
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.62
Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.55
← Prevpg 2/3Next →

Related Analyses (30)

Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived

Related Experiments (9)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45

See Also (1)

Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 3 hypotheses

Knowledge Graph (7 edges)

h-2901c57778 targets ent-gene-efa85237
ent-gene-efa85237 targeted_by h-2901c57778
ent-gene-efa85237 data_in benchmark_ot_ad_answer_key:NFL
benchmark_ot_ad_answer_key:NFL data_in ent-gene-efa85237
h-var-c261b9d0cd targets ent-gene-efa85237
ent-gene-efa85237 targeted_by h-var-c261b9d0cd
39720677 identified patients for ent-gene-efa85237

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.